GeneDx Holdings Corp. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported revenue was USD 48.71 million compared to USD 36.17 million a year ago. Net loss was USD 46.72 million compared to USD 85.74 million a year ago. Basic loss per share from continuing operations was USD 1.84 compared to USD 8.38 a year ago.
For the six months, revenue was USD 91.85 million compared to USD 90.11 million a year ago. Net loss was USD 107.71 million compared to USD 162.64 million a year ago. Basic loss per share from continuing operations was USD 4.73 compared to USD 18.42 a year ago.